M Scott Rocklage

Affiliations

  • Large Shareholder at Skye Bioscience Inc. (SKYE), 2024-09-13
  • Large Shareholder at Pear Therapeutics Inc. (PEAR), 2023-04-12
  • Large Shareholder at Rallybio Corp (RLYB), 2023-03-09
  • Large Shareholder at Akouos Inc. (AKUS), 2022-12-02
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2022-10-11
  • Large Shareholder at Entrada Therapeutics Inc. (TRDA), 2021-11-05
  • Large Shareholder at Cabaletta Bio Inc. (CABA), 2021-11-03
  • Large Shareholder at Impel Neuropharma Inc (IMPL), 2021-04-30
  • Large Shareholder at Homology Medicines Inc. (FIXX), 2020-12-29
  • Large Shareholder at Ideaya Biosciences Inc. (IDYA), 2020-11-14
  • Other at Aprea Therapeutics Inc. (APRE), 2020-10-08
  • Large Shareholder at Arvinas Inc. (ARVN), 2019-09-19
  • Other at Crinetics Pharmaceuticals Inc. (CRNX), 2019-06-25
  • Director at Cidara Therapeutics Inc. (CDTX), 2018-06-16
  • Other at Audentes Therapeutics Inc. (BOLD), 2017-04-27
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-23
  • Director at Pulmatrix Inc. (PULM), 2015-06-25
  • Large Shareholder, Director at Epirus Biopharmaceuticals Inc. (EPRS), 2015-06-08
  • Large Shareholder at Viveve Medical Inc. (VIVMF), 2015-05-29
  • Director at Achaogen Inc (AKAO), 2014-03-13
  • Large Shareholder, Director at Relypsa Inc (RLYP), 2013-11-21
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PULM $6.88 4,815 Director 168,873 2015-06-16 Filing
PULM $6.88 33,990 Director 1,192,154 2015-06-16 Filing
EPRS $5.00 389,950 Large Shareholder, Director 2,549,211 2015-02-04 Filing
EPRS $5.00 10,050 Large Shareholder, Director 65,699 2015-02-04 Filing
RLYP $11.00 9,364 Large Shareholder, Director 62,316 2013-11-20 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
APRE $33.30 4,807 Large Shareholder, Director 75,965 2020-06-16 Filing
APRE $33.30 115,357 Large Shareholder, Director 1,823,192 2020-06-16 Filing
APRE $28.75 9,800 Large Shareholder, Director 80,772 2020-06-11 Filing
APRE $28.75 235,200 Large Shareholder, Director 1,938,549 2020-06-11 Filing
APRE $35.15 10,200 Director 90,572 2020-05-19 Filing